Key result
Anti-inflammatory therapies for HF show patient-specific efficacy driven by highly variable biological and logistical factors.
Why the study?
Recent successful clinical outcomes of anti-inflammatory therapies in HF patients have increased interest in researching the role of inflammation in HF development.
Design
Review
Authors
Loading...
Warrants caution against broad use in HF; leaves open refined patient stratification in prospective trials.
This review provides a comprehensive overview of anti-inflammatory strategies in heart failure, emphasizing the evolving understanding of inflammation in the context of comorbidities like obesity, diabetes, and autoimmune diseases.
Taylor et al. (2025) conducted a review in Heart failure. Anti-inflammatory therapies was evaluated. Anti-inflammatory therapies for heart failure demonstrate patient-specific therapeutic efficacy that is driven by highly variable biological and logistical factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: